Vijay Parmar |
|
M. Pharma.
|
|
University of Veterinary Medicine in Vienna
·
Charotar University Science & Technology
|
Skills (8)
-
10 Questions202 Followers
-
3 Questions50 Followers
-
7 Questions8 Followers
-
0 Questions0 Followers
-
0 Questions0 Followers
-
45 Questions1225 Followers
Research experience
-
Jan 2012
Research: Charotar University of Science and Technology
Charotar University of Science and TechnologyIndia · Ānand -
Jan 2006–
Dec 2007Research: L. M. College of Pharmacy, Ahmedabad
L. M. College of Pharmacy, AhmedabadIndia · Ahmadābād -
Jul 2003–
Jan 2004Research: Estimation of Boswellic Acids from the Market Formulations Containing Boswellia serrata Extract by HPLC and HPTLC method
L. M. College of Pharmacy · Quality Assurance · L. M. College of PharmacyAhmedabad -
Dec 2002–
Jun 2003Research: Estimation of 11-keto β-boswellic acid in human plasma by high-performance thin-layer chromatography
L. M. College of Pharmacy · Quality Assurance · L. M. College of PharmacyAhmedabad
Education
-
May 2002–
Oct 2004Gujarat University
M. Pharm.India · Ahmedabad
Awards & achievements
-
Aug 2004Award: GUJCOST state level paper presentation competion
Other
-
LanguagesEnglish
Questions and Answers (6) View all
-
Answer added in Pharmaceutical Cocrystals2 Leadership crisisBy Sunil Varughese · National Institute for Interdisciplinary Science and TechnologyVijay Parmar · University of Veterinary Medicine in ViennaI agree with his comment. There should be Research Committee that direct Indian scientist toward the critical problems that our industries and commun... [more]I agree with his comment. There should be Research Committee that direct Indian scientist toward the critical problems that our industries and community are facing related to the science.Following
-
Answer added in Pharmaceutical Cocrystals3 HydratesBy Sunil Varughese · National Institute for Interdisciplinary Science and TechnologyVijay Parmar · University of Veterinary Medicine in ViennaYes this example can be kept in both the category co-crystal or solvate. But if we talk about only pharmaceutical co-crystals (API + co-crystal form... [more]Yes this example can be kept in both the category co-crystal or solvate. But if we talk about only pharmaceutical co-crystals (API + co-crystal former) then most of the API are in solid state at RT, only we have to see that for co-former and we can categorize accordingly the Pharmaceutical co-crystal or solvate. As per my opinion there should be clear cut distinguishing criteria for co-crystal and solvate particularly for the physical state because it may affect the stability.Following
-
Answer added in Pharmaceutical Cocrystals3 HydratesBy Sunil Varughese · National Institute for Interdisciplinary Science and TechnologyVijay Parmar · University of Veterinary Medicine in ViennaLooking to the different definitions proposed by researchers, pharmaceutical co-crystals are combination of two or more distinct compounds, which are ... [more]Looking to the different definitions proposed by researchers, pharmaceutical co-crystals are combination of two or more distinct compounds, which are solid at ambient condition, in a single crystal lattice. So i believe that physical state of co-former will determine whether it is hydrate or co-crystal.Following
-
Answer added in Pharmaceutical Cocrystals8 Why pharmaceutical cocrystals ?By Vijay Parmar · University of Veterinary Medicine in ViennaVijay Parmar · University of Veterinary Medicine in ViennaWhat may be the possible mechanisms behind change physicochemical properties of API present in pharmaceutical cocrystals?What may be the possible mechanisms behind change physicochemical properties of API present in pharmaceutical cocrystals?Following
-
Answer added in Pharmaceutical Cocrystals8 Why pharmaceutical cocrystals ?By Vijay Parmar · University of Veterinary Medicine in ViennaVijay Parmar · University of Veterinary Medicine in ViennaPharmaceutical co-crystals are subset of broader group of multicomponent systems. Pharmaceutical co-crystals differ from salts. This distinction i... [more]Pharmaceutical co-crystals are subset of broader group of multicomponent systems. Pharmaceutical co-crystals differ from salts. This distinction is based on whether a proton transfer has occurred from an acid to a base. Pharmaceutical co-crystals differ also from solvates. This difference is based on the physical state of the isolated pure components.Following
Publications (14) View all
-
Article: Hydrochloride salt co-crystals: preparation, characterization and physicochemical studies.
Vijaykumar K Parmar, Shailesh A Shah[show abstract] [hide abstract]
ABSTRACT: Co-crystallization approach for modification of physicochemical properties of hydrochloride salt is presented. The objective of this investigation was to study the effect of co-crystallization with different co-crystal formers on physicochemical properties of fluoxetine hydrochloride (FH). FH was screened for co-crystallization with a series of carboxylic acid co-formers by slow evaporation method. Photomicrographs and melting points of crystalline phases were determined. The co-crystals were characterized by FTIR, DSC and PXRD methods. Solubility of co-crystals was determined in water and buffer solutions. Powder and intrinsic dissolution profiles were assessed for co-crystals. Physical mixtures of drug and co-formers were used for comparisons at characterizations and physicochemical properties evaluation stages. Four co-crystals of FH viz. Fluoxetine hydrochloride-maleic acid (FH-MA), Fluoxetine hydrochloride-glutaric acid (FH-GA), Fluoxetine hydrochloride-L-tartaric acid (FH-LTA) and Fluoxetine hydrochloride-DL-tartaric acid (FH-DLTA) were obtained from screening experiments. Physical characterization showed that they have unique crystal morphology, thermal, spectroscopic and X-ray diffraction properties. Solubility and dissolution studies showed that Fluoxetine hydrochloride-maleic acid co-crystal possess high aqueous solubility in distilled water, pH 4.6, 7.0 buffer solutions and dissolution rate in distilled water than that of pure drug. Co-crystal formation approach can be used for ionic API to tailor its physical properties.Pharmaceutical Development and Technology 06/2012; · 1.36 Impact Factor -
Article: RP-HPLC Method for Estimation of Nitazoxanide in Oral Suspension Formulation
[show abstract] [hide abstract]
ABSTRACT: A simple, precise, accurate, rapid and reproducible reverse phase high performance liquid chromatographic method was developed for estimation of Nitazoxanide in oral suspension formulation. The mixture of acetonitrile: ammonium dihydrogen phosphate buffer (0.075 M) in the ratio 45:55 (% v/v) adjusted to pH 3.0 with ortho-phosphoric acid was used as mobile phase. The detection of the Nitazoxanide in oral suspension formulation was carried out at 240 nm and flow rate was set to 1.5 ml/min. Linearity was obtained in the concentration range of 5 to 25 µg/mL of Nitazoxanide with correlation coefficients of 0.997. The results of the analysis were validated statistically and recovery studies confirmed the accuracy of the proposed method.Der Pharma Chemica 0975-413X. 01/2012; 4(3):1140-1144. -
Article: Development of QSAR model for prediction of fold selectivity of phenyl benzoxazole as estrogen receptor inhibitors
[show abstract] [hide abstract]
ABSTRACT: QSAR model development of 37 phenyl benzoxazole was carried out to predict the fold selectivity for estrogen receptor. The ratio of IC50 for estrogen receptor-α and estrogen receptor-β (fold selectivity) was taken as biological activity. Physicochemical parameters were calculated using Dragon software, version 1.11. Sequential multiple linear regression analysis was carried out to derive QSAR models, which were further evaluated for statistical significance and predictive power by internal and external validation. The best quantitative structure activity relationship model was selected having a correlation coefficient (R2) of 0.948, cross-validated correlation coefficient (Q2) of 0.921 and, R2pred of 0.853. The predictive ability of the selected model was also confirmed by leave one-out cross-validation. The QSAR model indicates that the descriptors (H1p, R5u, RTe) play an important role in estrogen receptor-β binding. The information generated from the present study may be useful in the design of more potent substituted phenyl benzoxazole derivatives as estrogen receptor ligands.Medicinal Chemistry Research 11/2011; · 1.27 Impact Factor -
Article: Development of QSAR model for indoyl aryl sulfone derivatives as reverse transcriptase inhibitors
[show abstract] [hide abstract]
ABSTRACT: QSAR model development of 39 indoyl aryl sulfones was carried out to predict reverse transcriptase inhibition activity. EC50 for reverse transcriptase binding was taken as biological activity. Physicochemical parameters were calculated using PaDEL descriptor software, version 2.1. Stepwise multiple linear regression analysis was applied to derive QSAR models, which were further evaluated for statistical significance and predictive power by internal and external validation. The best quantitative structure activity relationship model was selected having a correlation coefficient (R2) of 0.835, cross-validated correlation coefficient (Q2) of 0780 and, R2pred of 0.830. The predictive ability of the selected model was also confirmed by leave one-out cross-validation. The QSAR model indicates that the descriptors (nHBint, SaaNH, MDEO-11 and minaaaC) play an important role in enzyme binding. The information derived from the present study may be useful in the design of more potent substituted indoyl aryl sulfones.Der Pharma Chemica. 06/2011; 6(3-ISSN 0975-413X):53-61. -
Article: A simple high-performance liquid chromatographic method for the estimation of boswellic acids from the market formulations containing Boswellia serrata extract.
[show abstract] [hide abstract]
ABSTRACT: A simple, rapid, and reproducible reverse-phase high-performance liquid chromatographic method is developed for the estimation of boswellic acids, the active constituents in Boswellia serrata oleo-gum resin. The chromatographic separation is performed using a mobile phase consisting of acetonitrile-water (90:10, % v/v) adjusted to pH 4 with glacial acetic acid on a Kromasil 100 C18 analytical column with flow rate of 2.0 mL/min and detection at 260 nm. The elution times are 4.30 and 7.11 min for 11-keto beta-boswellic acid (11-KBA) and 3-acetyl 11-keto beta-boswellic acid (A-11-KBA), respectively. The calibration curve is linear in the 11.66-58.30 microg/mL and 6.50-32.50 microg/mL range for 11-KBA and A-11-KBA, respectively. The limits of detection are 2.33 microg/mL and 1.30 microg/mL for 11-KBA and A-11-KBA, respectively. The mean recoveries are 98.24% to 104.17% and 94.12% to 105.92% for 11-KBA and A-11-KBA, respectively. The inter- and intra-day variation coefficients are less than 5%. The present method is successfully applied for the estimation of boswellic acids from the market formulations containing Boswellia serrata extract.Journal of chromatographic science 10/2008; 46(8):735-8. · 0.88 Impact Factor